Harper L, Savage C O
Department of Renal Immunobiology, Medical Research Council Center for Immune Regulation, University of Birmingham Medical School, Edgbaston, Birmingham, United Kingdom.
Rheum Dis Clin North Am. 2001 Nov;27(4):887-903. doi: 10.1016/s0889-857x(05)70241-6.
The etiology of ANCA-associated vasculitis is unknown. Currently, it is believed that disease may be triggered by infection with the release of proinflammatory cytokines in genetically susceptible individuals. Priming of PMNs and endothelial cells by these cytokines allows ANCAs to activate PMNs, with damage localized to the endothelium, resulting in early lesions. Damage and activation of endothelial cells produces proinflammatory chemokines and cytokines with influxes of monocytes and T cells that intensify endothelial damage. In the kidney, these changes eventually lead to crescent formation. Antigen-specific memory T cells persist after disease remission with the potential of reactivation and disease relapse. Although our understanding of the pathophysiologic mechanisms of ANCA-associated vasculitis is far greater now than when ANCAs were first identified in 1982, more experimental work in combination with clinical observations is required to further elucidate these mechanisms.
抗中性粒细胞胞浆抗体(ANCA)相关血管炎的病因尚不清楚。目前认为,在基因易感个体中,感染引发促炎细胞因子释放可能触发疾病。这些细胞因子对多形核白细胞(PMN)和内皮细胞的致敏作用使ANCA能够激活PMN,损伤局限于内皮,导致早期病变。内皮细胞的损伤和激活产生促炎趋化因子和细胞因子,单核细胞和T细胞流入,加剧内皮损伤。在肾脏中,这些变化最终导致新月体形成。疾病缓解后,抗原特异性记忆T细胞持续存在,有重新激活和疾病复发的可能。尽管我们目前对抗中性粒细胞胞浆抗体相关血管炎病理生理机制的理解比1982年首次发现ANCA时要深入得多,但仍需要更多的实验工作结合临床观察来进一步阐明这些机制。